ライフサイエンスコーパス: cardiac tamponade

1 tion and technical surgical factors, such as cardiac tamponade).

2 with acute myocardial infarction and 1 with cardiac tamponade).

3 ve US examinations and returned with delayed cardiac tamponade.

4 to a reference standard for the diagnosis of cardiac tamponade.

5 basic diagnostic tests for the diagnosis of cardiac tamponade.

6 r malposition, pneumothorax, hemothorax, and cardiac tamponade.

7 ving implants, 4 patients (8.9%) experienced cardiac tamponade.

8 rgical intervention (0.9%), and 1 episode of cardiac tamponade (0.9%) requiring pericardiocentesis.

9 patients (2.7%) experienced complications: 5 cardiac tamponades (1.4%), 4 pseudoaneurysms (1.1%), and

10 es, but adverse events included 1 episode of cardiac tamponade, 1 stroke without residual defect, and

11 , the presence of pericardial effusion (1C), cardiac tamponade (1B), valvular dysfunction (1C), endoc

12 Among patients with cardiac tamponade, a minority will not have dyspnea, tac

13 There was a 2% incidence of cardiac tamponade and a 2.5% incidence of phrenic nerve

14 ith Mycoplasma pneumoniae that progressed to cardiac tamponade and constrictive pericarditis.

15 They included one episode of cardiac tamponade and one myocardial infarction in the h

16 remained stable over time, whereas rates of cardiac tamponade and pacemaker implantation significant

17 A case of hemopericardium, cardiac tamponade, and death caused by perforation of th

18 as death, myocardial infarction, stroke, or cardiac tamponade, and feasibility, defined as successfu

19 l bleeding, spontaneous hemopericardium with cardiac tamponade, and hemarthrosis in 11, 7, 1, and 1 p

20 teric ischemia, kidney failure, hypotension, cardiac tamponade, and limb ischemia) were increased in

21 disseminated intravascular coagulopathy, and cardiac tamponade, and the patient died on the fourth ho

22 ergoing device implantation procedures, with cardiac tamponade being the most common cause of death.

23 dial temperature, without the development of cardiac tamponade, can be attained using a pericardial c

24 may require emergency pericardiocentesis if cardiac tamponade develops.

25 her adverse events including cardiac arrest, cardiac tamponade, device infection, pneumothorax, and i

26 perform pericardiocentesis in patients with cardiac tamponade diagnosed by echocardiography.

27 One patient (treatment group) had a cardiac tamponade during mapping.

28 developed right ventricular perforation and cardiac tamponade during the implant procedure, and even

29 mplication rate (perforation with or without cardiac tamponade, embolization) was 0.33% for LVEMB and

30 No intraprocedural deaths, cardiac tamponade, emergency surgery, stroke, myocardial

31 r the quick identification and management of cardiac tamponade even in procedures typically believed

32 ardial effusion helps distinguish those with cardiac tamponade from those without.

33 Major bleeding was defined as either cardiac tamponade, hematoma that required intervention,

34 Three patients (0.4%) had cardiac tamponade/hemopericardium, and 5 patients (0.7%)

35 ected patients are pericardial effusion with cardiac tamponade, high-grade arrhythmia with sudden car

36 bleeding (HR: 2.01 [95% CI: 0.91 to 4.44]), cardiac tamponade (HR: 2.38 [95% CI: 0.56 to 10.1]), and

37 re-related stroke; there were three cases of cardiac tamponade in the ablation group.

38 Cardiac tamponade is a potentially life-threatening proc

39 Cardiac tamponade is a state of hemodynamic compromise r

40 Cardiac tamponade is the most dramatic complication obse

41 Major hemorrhage or cardiac tamponade leading to reoperation occurred in 1.4

42 One other patient experienced cardiac tamponade, leading to termination of the procedu

43 tourinary bleeding; intracranial hemorrhage; cardiac tamponade; nonbypass surgery-related blood trans

44 patients in the placebo group (P=0.75), and cardiac tamponade occurred at rates of 1.1% and 0.4%, re

45 0.67; 95% CI, 0.31-1.43; P=0.30), including cardiac tamponade (OR, 0.69; 95% CI, 0.19-2.47; P=0.57).

46 of cardiac arrest, e.g., pulmonary embolism, cardiac tamponade, or hypovolemia, and signal the return

47 pericardial complications (hemopericardium, cardiac tamponade, or pericardiocentesis), pneumothorax,

48 Cardiac tamponade, permanent pacemaker implantation, maj

49 y efficacy outcome was a composite of death, cardiac tamponade requiring pericardiocentesis, or const

50 ignificant effect on the composite of death, cardiac tamponade requiring pericardiocentesis, or const

51 No death, cardiac tamponade, ventricular arrhythmia, or other proc

52 Cardiac tamponade was less common in PCS patients (P=0.0

53 Overall, cardiac tamponade was the most frequent direct cause of

54 es were reported in either group; 4 cases of cardiac tamponade were reported in the ablation group.